The guideline for deprescribing proton pump inhibitors was developed collaboratively by a team of pharmacists, family physicians and medical researchers in association with members of the Cochrane Collaboration using established methods to synthesize evidence and formulate recommendations.
Below are two videos — one that illustrates how the evidence-based deprescribing guidelines were developed and a second illustrating how to use the deprescribing algorithm for proton pump inhibitors (PPIs). To help us evaluate and improve the videos please consider taking a few minutes to complete a survey.
VIDEO 1: Developing deprescribing guidelines to help manage polypharmacy and improve outcomes for patients
Evidence-based deprescribing guidelines are tools to help you decide when and how to reduce medications that may no longer be needed, or may be causing more harm than benefit.
This video helps you understand —
- the rationale for evidence-based deprescribing guidelines
- the process used for developing the deprescribing guidelines
- the steps that a healthcare professional and patient need to go through to make and carry out safe deprescribing processes
VIDEO 2: Using the PPI deprescribing algorithm — when to reduce or stop PPIs and how?
Proton pump inhibitors or PPIs are a class of drugs used to treat heartburn, gastroesphageal reflux disease and gastric ulcers.
This video provides an overview of how to use an evidence-based PPI deprescribing algorithm to help you decide when and how to safely reduce or stop PPIs if they are no longer needed, or possibly causing more harm than benefit. It also highlights the situations in which people should continue their PPIs.
We’d like to know what you think of the whiteboard video on using the deprescribing algorithm for PPIs. Please click the link of the survey that applies to you.